Machine learning for comprehensive forecasting of Alzheimer's Disease progression.
Saved in:
| Title: | Machine learning for comprehensive forecasting of Alzheimer's Disease progression. |
|---|---|
| Authors: | Fisher CK; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. drckf@unlearn.ai., Smith AM; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA., Walsh JR; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. |
| Corporate Authors: | Coalition Against Major Diseases, Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute. |
| Source: | Scientific reports [Sci Rep] 2019 Sep 20; Vol. 9 (1), pp. 13622. Date of Electronic Publication: 2019 Sep 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31541187 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Machine learning for comprehensive forecasting of Alzheimer's Disease progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fisher+CK%22">Fisher CK</searchLink>; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. drckf@unlearn.ai.<br /><searchLink fieldCode="AU" term="%22Smith+AM%22">Smith AM</searchLink>; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Walsh+JR%22">Walsh JR</searchLink>; Unlearn.AI, Inc., 450 Geary St, San Francisco, CA, 94102, San Francisco, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Coalition+Against+Major+Diseases%22">Coalition Against Major Diseases</searchLink><br /><searchLink fieldCode="CA" term="%22Abbott%2C+Alliance+for+Aging+Research%2C+Alzheimer%27s+Association%2C+Alzheimer%27s+Foundation+of+America%2C+AstraZeneca+Pharmaceuticals+LP%2C+Bristol-Myers+Squibb+Company%2C+Critical+Path+Institute%2C+CHDI+Foundation%2C+Inc%2E%2C+Eli+Lilly+and+Company%2C+F%2E+Hoffmann-La+Roche+Ltd%2C+Forest+Research+Institute%2C+Genentech%2C+Inc%2E%2C+GlaxoSmithKline%2C+Johnson+%26+Johnson%2C+National+Health+Council%2C+Novartis+Pharmaceuticals+Corporation%2C+Parkinson%27s+Action+Network%2C+Parkinson%27s+Disease+Foundation%2C+Pfizer%2C+Inc%2E%2C+sanofi-aventis%2E+Collaborating+Organizations%3A+Clinical+Data+Interchange+Standards+Consortium+%28CDISC%29%2C+Ephibian%2C+Metrum+Institute%2E%22">Abbott, Alliance for Aging Research, Alzheimer’s Association, Alzheimer’s Foundation of America, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Critical Path Institute, CHDI Foundation, Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Forest Research Institute, Genentech, Inc., GlaxoSmithKline, Johnson & Johnson, National Health Council, Novartis Pharmaceuticals Corporation, Parkinson’s Action Network, Parkinson’s Disease Foundation, Pfizer, Inc., sanofi-aventis. Collaborating Organizations: Clinical Data Interchange Standards Consortium (CDISC), Ephibian, Metrum Institute.</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2019 Sep 20; Vol. 9 (1), pp. 13622. <i>Date of Electronic Publication: </i>2019 Sep 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31541187 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-019-49656-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 13622 Titles: – TitleFull: Machine learning for comprehensive forecasting of Alzheimer's Disease progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fisher CK – PersonEntity: Name: NameFull: Smith AM – PersonEntity: Name: NameFull: Walsh JR IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 09 Text: 2019 Sep 20 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 9 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |